The global chimeric antigen receptor (CAR) T-cell therapy market , valued at USD 2.54 billion in 2022, is expected to experience robust growth, reaching USD 3.5 billion by the end of 2023 and eventually accumulating USD 6.82 billion by 2033. This growth reflects a compound annual growth rate (CAGR) of 6.9% over the forecast period …